Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Somberg

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
American Journal of Therapeutics|July 11, 2013
The Supremes got it rightJohn Somberg
American Journal of Therapeutics|May 9, 2012
Is there an imperative for generic profiling to hasten the age of personalized medicineJohn Somberg
The American Journal of Cardiology|August 28, 2007
Patent foramen ovale closure devices: thoughts from the circulatory device advisory panelJohn Somberg
American Journal of Therapeutics|January 8, 2009
The drug eluting stent challengeJohn Somberg
American Journal of Therapeutics|September 9, 2015
Angiotensin-Neprilysin Combinations Marketing Poly or Therapeutic OptimizationJohn Somberg
Cardiology Research|June 5, 2020
Let Us Aggressively Confront the Coronavirus PandemicJohn Somberg
American Journal of Therapeutics|January 10, 2012
Guidelines or 10 commandmentsJohn Somberg
American Journal of Therapeutics|November 16, 2004
The politics of therapeuticsJohn Somberg
American Journal of Therapeutics|July 21, 2009
Health care reformJohn Somberg
American Journal of Therapeutics|July 26, 2005
Intellectual propertyJohn Somberg
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
American Journal of Therapeutics|July 11, 2013
The Supremes got it rightJohn Somberg
American Journal of Therapeutics|May 9, 2012
Is there an imperative for generic profiling to hasten the age of personalized medicineJohn Somberg
The American Journal of Cardiology|August 28, 2007
Patent foramen ovale closure devices: thoughts from the circulatory device advisory panelJohn Somberg
American Journal of Therapeutics|January 8, 2009
The drug eluting stent challengeJohn Somberg
American Journal of Therapeutics|September 9, 2015
Angiotensin-Neprilysin Combinations Marketing Poly or Therapeutic OptimizationJohn Somberg
Cardiology Research|June 5, 2020
Let Us Aggressively Confront the Coronavirus PandemicJohn Somberg
American Journal of Therapeutics|January 10, 2012
Guidelines or 10 commandmentsJohn Somberg
American Journal of Therapeutics|November 16, 2004
The politics of therapeuticsJohn Somberg
American Journal of Therapeutics|July 21, 2009
Health care reformJohn Somberg
American Journal of Therapeutics|July 26, 2005
Intellectual propertyJohn Somberg
Pageof 8